Zota Health Care LImited Stock Price Today (NSE: ZOTA)
Fundamental Score
Zota Health Care LImited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Zota Health Care LImited share price today is ₹1356.00, up +5.30% on NSE/BSE as of 22 September 2026. Zota Health Care LImited (ZOTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹4.70K (Cr). The 52-week high for ZOTA share price is ₹1740.00 and the 52-week low is ₹1022.00. The company has a Return on Equity (ROE) of -16.12% and a debt-to-equity ratio of 0.04.
Zota Health Care LImited Share Price Chart — NSE/BSE Historical Performance
Zota Health Care LImited share price chart: -12.40% return over the past month. 52-week high ₹1740.00, 52-week low ₹1022.00.
Zota Health Care LImited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1124.90 | ₹1155.00 | ₹1124.90 | ₹1144.50 | 56.56K (Cr) | |
| ₹1114.10 | ₹1152.00 | ₹1107.80 | ₹1118.80 | 1.23L (Cr) | |
| ₹1108.40 | ₹1119.50 | ₹1095.00 | ₹1114.10 | 31.80K (Cr) | |
| ₹1088.00 | ₹1124.00 | ₹1088.00 | ₹1113.10 | 53.20K (Cr) | |
| ₹1100.00 | ₹1103.80 | ₹1081.00 | ₹1087.20 | 22.93K (Cr) | |
| ₹1115.00 | ₹1118.80 | ₹1081.90 | ₹1099.50 | 37.28K (Cr) | |
| ₹1105.80 | ₹1123.90 | ₹1095.90 | ₹1114.30 | 42.34K (Cr) | |
| ₹1100.10 | ₹1120.00 | ₹1086.10 | ₹1113.10 | 49.56K (Cr) | |
| ₹1138.10 | ₹1138.10 | ₹1087.00 | ₹1089.70 | 29.56K (Cr) | |
| ₹1100.00 | ₹1159.30 | ₹1100.00 | ₹1132.40 | 91.90K (Cr) |
Zota Health Care LImited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1055.00 | ₹1159.30 | ₹1022.00 | ₹1144.50 | +8.48% | |
| ₹1290.00 | ₹1309.00 | ₹1050.00 | ₹1053.80 | -18.31% | |
| ₹1432.40 | ₹1478.00 | ₹1213.00 | ₹1279.30 | -10.69% | |
| ₹1120.10 | ₹1445.00 | ₹1110.00 | ₹1416.80 | +26.49% | |
| ₹1311.20 | ₹1350.90 | ₹1100.00 | ₹1125.20 | -14.19% | |
| ₹1114.80 | ₹1364.90 | ₹1060.00 | ₹1311.20 | +17.62% | |
| ₹1200.00 | ₹1241.90 | ₹1026.20 | ₹1064.80 | -11.27% | |
| ₹1290.00 | ₹1429.80 | ₹1200.00 | ₹1215.10 | -5.81% | |
| ₹1550.00 | ₹1552.60 | ₹1181.20 | ₹1288.50 | -16.87% | |
| ₹1598.00 | ₹1714.70 | ₹1496.00 | ₹1544.70 | -3.34% | |
| ₹1518.00 | ₹1740.00 | ₹1501.00 | ₹1574.30 | +3.71% | |
| ₹1421.00 | ₹1627.70 | ₹1375.60 | ₹1511.00 | +6.33% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Zota Health Care LImited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Zota Health Care LImited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZOTA across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (204.24%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (67.60%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (38.22% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.04)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 1.93)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (51.56%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
5 factors identified
Below-Average Return on Equity (-16.12%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-10.14%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
High Price-to-Book Ratio (6.77x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Weak Interest Coverage (-3.60x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-207.48 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Zota Health Care LImited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Zota Health Care LImited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
38/100 | ₹1356.00₹1356 | ₹4696.18₹4696.18 | — — | -16.12%Poor -16.12% Poor | -10.14%Poor -10.14% Poor | 0.04Excellent 0.0 Excellent | — — | 38.22%Excellent 38.22% Excellent | 0.07% | |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Zota Health Care LImited PE Ratio History
Historical price-to-earnings ratio for ZOTA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2022 | ₹3.58 | ₹303.65 | 84.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Zota Health Care LImited Dividend History
Annual cash dividends paid by ZOTA — dividend yield 0.07%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.74 Cr |
| FY 2024 | ₹2.58 Cr |
| FY 2023 | ₹3.77 Cr |
| FY 2022 | ₹2.52 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Zota Health Care LImited Quarterly Performance
Latest quarterly metrics for ZOTA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
67.60%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
204.24%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
38.22%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Zota Health Care LImited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ZOTA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Zota Health Care LImited Financial Statements
Annual income statement, balance sheet and cash flow for Zota Health Care LImited (ZOTA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Zota Health Care LImited
About ZOTA (Zota Health Care LImited)
Zota Health Care Limited is a dynamic and rapidly expanding pharmaceutical company carving a distinctive niche within the Indian and global healthcare landscape. With a firm commit...ment to improving lives through accessible and affordable medicine, Zota meticulously formulates and produces a diverse range of pharmaceutical solutions. This portfolio encompasses a broad spectrum of therapeutic areas, from mainstream generic medications to specialized nutraceuticals and time-honored ayurvedic remedies. Driven by innovation and a patient-centric approach, Zota endeavors to meet the evolving needs of a diverse population, offering both prescription-based drugs and readily available over-the-counter products designed to promote well-being and address a variety of health concerns. At the heart of Zota's operations lies a state-of-the-art manufacturing infrastructure, meticulously designed to adhere to the most stringent international quality standards. This unwavering dedication to quality assurance permeates every aspect of the company's processes, from raw material sourcing to final product packaging. Beyond manufacturing excellence, Zota distinguishes itself through its robust distribution network, ensuring that its pharmaceutical products reach patients and healthcare providers across various geographical regions. The company prides itself on fostering strong relationships with its stakeholders, including distributors, retailers, and medical professionals, further solidifying its presence and contributing to the overall accessibility of its healthcare solutions. Zota Health Care Limited demonstrates a forward-thinking approach to healthcare delivery, exemplified by its unique retail initiative, DAVAINDIA. This network of retail stores serves as a direct conduit to consumers, providing access to affordable medicines and health-related products. DAVAINDIA stores embody Zota's commitment to empowering individuals to take control of their health and well-being, offering not only pharmaceutical products but also valuable information and support. With a rich heritage rooted in ethical business practices and a clear vision for the future, Zota Health Care Limited is poised to continue its trajectory of growth, impacting lives positively and shaping the future of healthcare.
Company Details
Key Leadership
ZOTA Share Price: Frequently Asked Questions
What is the current share price of Zota Health Care LImited?
Zota Health Care LImited (ZOTA) trades at ₹1356.00 on NSE. Market cap ₹4.70K (Cr). Educational data only.
What is the P/E ratio of Zota Health Care LImited?
Zota Health Care LImited has a P/E of N/Ax vs industry average 34.89x.
What is the Bull Run score for Zota Health Care LImited?
Zota Health Care LImited has a Bull Run score of 38/100 based on 25+ financial parameters.
Does Zota Health Care LImited pay dividends?
Zota Health Care LImited has a dividend yield of 0.07%. Past dividends don't guarantee future payments.
What is the ROE of Zota Health Care LImited?
Zota Health Care LImited has ROE of -16.12%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Zota Health Care LImited?
Zota Health Care LImited has debt-to-equity of 0.04.
Is Zota Health Care LImited a good investment?
Bull Run gives Zota Health Care LImited a score of 38/100. This is not investment advice — consult a SEBI-registered advisor.